| 常用名 | CDK12 inhibitor E9 S-isomer | CAS号 | 2020052-55-3 |
|---|---|---|---|
| 价格 | 纯度 | 99.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: CDK12 inhibitor E9 S-isomer (E9, CDK12-IN-E9) is a clinical analog of THZ1 and a selective, covalent CDK12 inhibitor that is not susceptible to ABC transporter-mediated drug efflux; dose-dependently decreases phosphorylated and total RNAPII in THZ1R NB and lung cancer models, competed strongly with bio-THZ1 for binding to CDK12 at low nanomolar ranges, but not CDK7 (>1 uM); exerts its cytotoxic effects through covalent modification of cysteine 1039 of CDK12; shows more potent antiproliferative activity in THZ1R NB and lung cancer cells with IC50 ranging from 8 to 40 nM than ribociclib, palbociclib, and AZD5438. 物理化学性质: CAS号:2020052-55-3 常用中文名:CDK12 inhibitor E9 S-isomer 常用英文名:CDK12-IN-E9 分子式:C24H30N6O2 分子量:434.544 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |